MASSIMO T PIETROPAOLO

Summary

Affiliation: University of Michigan
Country: USA

Publications

  1. doi Persistent C-peptide: what does it mean?
    Massimo Pietropaolo
    Division of Metabolism, Endocrinology and Diabetes, Department of Internal Medicine, The Brehm Center for Diabetes Research, University of Michigan Medical School, Ann Arbor, Michigan 48105, USA
    Curr Opin Endocrinol Diabetes Obes 20:279-84. 2013
  2. ncbi The heterogeneity of diabetes: unraveling a dispute: is systemic inflammation related to islet autoimmunity?
    Massimo Pietropaolo
    Laboratory of Immunogenetics, The Brehm Center for Type 1 Diabetes and Analysis, Division of Metabolism, Endocrinology and Diabetes, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI 48109, USA
    Diabetes 56:1189-97. 2007
  3. pmc Humoral autoimmunity against the extracellular domain of the neuroendocrine autoantigen IA-2 heightens the risk of type 1 diabetes
    Michael P Morran
    Laboratory of Immunogenetics, The Brehm Center for Diabetes Research, 1000 Wall Street, Ann Arbor, Michigan 48105
    Endocrinology 151:2528-37. 2010

Research Grants

  1. Epidemiology of Heterogenity in Type 2 Diabetes
    Massimo Pietropaolo; Fiscal Year: 2009
  2. IMPROVING PREDICTION OF IDDM
    Massimo Pietropaolo; Fiscal Year: 2007
  3. Proteomics of Autoimmune Type 1 Diabetes
    Massimo Pietropaolo; Fiscal Year: 2006
  4. EPIDEMIOLOGY OF ISLET CELL AUTOIMMUNITY IN NIDDM
    Massimo Pietropaolo; Fiscal Year: 2003
  5. IMPROVING PREDICTION OF IDDM
    Massimo Pietropaolo; Fiscal Year: 2002
  6. Enhancement of Biomarkers for Type 1 Diabetes
    MASSIMO T PIETROPAOLO; Fiscal Year: 2010

Collaborators

Detail Information

Publications3

  1. doi Persistent C-peptide: what does it mean?
    Massimo Pietropaolo
    Division of Metabolism, Endocrinology and Diabetes, Department of Internal Medicine, The Brehm Center for Diabetes Research, University of Michigan Medical School, Ann Arbor, Michigan 48105, USA
    Curr Opin Endocrinol Diabetes Obes 20:279-84. 2013
    ..The purpose to this review is to highlight some of the key emerging evidence supporting residual insulin and C-peptide secretion in long-standing T1D...
  2. ncbi The heterogeneity of diabetes: unraveling a dispute: is systemic inflammation related to islet autoimmunity?
    Massimo Pietropaolo
    Laboratory of Immunogenetics, The Brehm Center for Type 1 Diabetes and Analysis, Division of Metabolism, Endocrinology and Diabetes, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI 48109, USA
    Diabetes 56:1189-97. 2007
    ..A more appropriate characterization of this subgroup of clinically diagnosed type 2 diabetes, diabetes of autoimmune pathogenesis, will promote future research into the etiology, natural history, and treatment...
  3. pmc Humoral autoimmunity against the extracellular domain of the neuroendocrine autoantigen IA-2 heightens the risk of type 1 diabetes
    Michael P Morran
    Laboratory of Immunogenetics, The Brehm Center for Diabetes Research, 1000 Wall Street, Ann Arbor, Michigan 48105
    Endocrinology 151:2528-37. 2010
    ....

Research Grants18

  1. Epidemiology of Heterogenity in Type 2 Diabetes
    Massimo Pietropaolo; Fiscal Year: 2009
    ..abstract_text> ..
  2. IMPROVING PREDICTION OF IDDM
    Massimo Pietropaolo; Fiscal Year: 2007
    ..abstract_text> ..
  3. Proteomics of Autoimmune Type 1 Diabetes
    Massimo Pietropaolo; Fiscal Year: 2006
    ..Novel surrogate markers that will be identified by this approach might ultimately aid in monitoring the response to therapy aimed at delaying or reversing the disease process. ..
  4. EPIDEMIOLOGY OF ISLET CELL AUTOIMMUNITY IN NIDDM
    Massimo Pietropaolo; Fiscal Year: 2003
    ..A more appropriate characterization of a subgroup of Type 2 diabetic patients of autoimmune pathogenesis will be of benefit to future research into the etiology, natural history as well as treatment of Type 2 diabetes mellitus. ..
  5. IMPROVING PREDICTION OF IDDM
    Massimo Pietropaolo; Fiscal Year: 2002
    ..abstract_text> ..
  6. Enhancement of Biomarkers for Type 1 Diabetes
    MASSIMO T PIETROPAOLO; Fiscal Year: 2010
    ....